Substance active (DCI)
- guanfacine (chlorhydrate)
Informations techniques
Exploitant
Laboratoire NOVARTIS PHARMA
Présentation
ESTULIC 2 mg, comprimé
B/30 : CIP 323 305-8
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
zd0RgVEr9VcvKPx3